The role of glyoxalase system in methylglyoxal detoxification. by MohammedBashar Al-Qazzan (22439236)

Subjects:

IC₅₀ values (mean ±SD in μM) of <i><i>in vitro</i></i> DPPH-radical scavenging properties vs. ascorbic acid and antiinflammation propensities vs. indomethacin of the tes... by MohammedBashar Al-Qazzan (22439236)

Subjects:

3D and 2D pose of the docked Shikonin diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

Subjects:

Classification of inactive compounds. by MohammedBashar Al-Qazzan (22439236)

Subjects:

Active compounds identified as glyoxalase-I inhibitors. by MohammedBashar Al-Qazzan (22439236)

Subjects:

The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... by MohammedBashar Al-Qazzan (22439236)

Subjects:

3D and 2D pose of the docked Tolcapone diagram displaying a variety of interactions with enzyme’s active region. by MohammedBashar Al-Qazzan (22439236)

Subjects:

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

PRV UL4 augments ASC oligomerization and speck formation. by Xiaohua Zhang (350570)

PRV UL4 interacts with ASC. by Xiaohua Zhang (350570)

Flow diagram showing number of subjects included in the study population. by Jung-Tae Kim (8997767)

Supplementary data. by Malte Ostendarp (13217973)

“…In contrast, the addition of hydrogen at 26 °C caused a significant decrease in the photophysiology of both <i>Acropora</i> sp. and <i>P. verrucosa</i>. …”

Data used to generate Figs 2–7 and S1 Fig. by Amy J. Schuh (8520354)

“…Compared to the MARV-monoinfected bat group, the SOSV+MARV-coinfected bat group exhibited a significantly shortened duration of MARV oral shedding and a significantly decreased anti-MARV IgG response, which may increase the capacity for MARV reinfection. …”

Cumulative MARV shedding in bats from the SOSV-MARV and KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

MARV shedding dynamics in bats from the SOSV-MARV experimental cohort. by Amy J. Schuh (8520354)

MARV shedding dynamics in bats from the KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

Pre- and post-study virus-specific IgG responses for bats in the SOSV-MARV and KASV-MARV experimental cohorts. by Amy J. Schuh (8520354)

SOSV loads in specimens obtained from bats in the SOSV-MARV experimental cohort. by Amy J. Schuh (8520354)